Cluster 2 with the predominant antibody of anti-SSA and anti-SSB was characterized by a high proportion of SjS, a high rate of IgG >ULN, and a low mortality rate during the follow-up period, which could explain the ability of anti-SSA to play a major role in this cluster. The gene discussed is SSB; the disease is Schwartz-Jampel syndrome.